SMN Corporation

SMN Corporation

TTSE:6185
332.00
JPY
-3.00
(-0.90%)
21.67EPS
17.77P/E
5.63BMarket Cap
Jan 29Next Earn
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
451.49
608.92
597.14
727.38
799.62
905.38
934.85
1,019.32
810.78
642.59
799.36
844.89
860.93
Basic EPS, GAAP
25.28
26.17
21.51
51.41
45.15
37.73
-2.96
-17.44
-8.3
-70.79
20.03
29.76
21.67
Free Cash Flow per Basic Share
1.63
-15.73
-0.22
8.83
16.25
32.06
-11.96
16.33
5.41
3.9
61.03
50.43
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
65.45
222.58
232.66
277.34
323.16
354.12
350.13
330.77
323.55
252.14
272.81
301.4
295.1
Tangible Book Value per Share
40.91
176.97
172.85
198.71
225.01
212.31
88.74
108.01
131.7
157.78
193.55
226.6
220.9
Basic Weighted Avg Shares
8
9
12
12
13
13
13
13
14
15
15
15
15
Sales/Revenue/Turnover
3,713
5,628
6,961
9,021
10,217
11,608
12,116
13,363
11,442
9,337
11,641
12,348
12,590
Operating Margin (%)
4.58
5.24
4.67
6.02
7.1
6.44
2.51
0.95
0.15
1.09
2.05
4.54
3.55
Depreciation Expense
48
111
190
274
381
521
631
882
819
836
551
521
- -
Net Income, GAAP
208
242
251
638
577
484
-38
-229
-117
-1,029
292
435
317
Effective Tax Rate (%)
- -
13.21
22.64
- -
19.51
34.22
118.9
- -
- -
- -
8.99
19.59
26.46
Profit Margin (%)
5.6
4.3
3.6
7.07
5.65
4.17
-0.32
-1.71
-1.02
-11.02
2.51
3.52
2.52
Working Capital
252
1,749
1,838
1,850
2,172
2,119
749
2,391
2,752
2,943
2,518
2,993
2,935
LT Debt
- -
- -
6
7
4
138
117
1,477
1,250
1,024
64
51
48
Total Equity
717
2,519
2,817
3,505
4,162
4,570
4,565
4,395
4,727
3,700
3,980
4,409
4,316
Return on Invested Capital (%)
- -
14.97
8.97
- -
14.5
10.59
-1.01
- -
- -
- -
4.68
10.13
7.58
Return on Capital (%)
- -
14.95
9.39
- -
15.03
10.94
-0.71
- -
- -
- -
6.77
10.42
7.69
Return on Common Equity (%)
- -
14.95
9.4
20.17
15.05
11.08
-0.84
-5.12
-2.58
-24.61
7.63
10.37
7.62

Capital Structure

JPY

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
13
12
12
LT Borrowings
54
51
48
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
15
15
15
Market Capitalization
6,728
5,661
5,631

Working Capital

JPY

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
4,406
5,000
4,481
Cash, Cash Equivalents & STI
3,028
3,188
3,185
Accounts Receivable, Net
1,230
1,698
1,123
Inventories
- -
- -
- -
Total Current Liabilities
1,634
2,007
1,546
Payables & Accruals
- -
- -
- -
ST Debt
13
12
12
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.52%
0.09%
10.77%
Free Cash Flow
-333.67%
224.5%
-17.07%
Net Income, GAAP
117.16%
229.45%
49.09%
Sales/Revenue/Turnover
9.28%
1.66%
6.08%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
2,889
2,702
2,703
3,347
11,641
2026
2,729
2,951
3,100
3,568
12,348
2027
2,971
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-3.94
-0.1
4.63
19.39
20.03
2026
1.28
6.97
4.65
16.85
29.76
2027
-6.79
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Naoki Harayama
Full Time Employees
240
Sector
Technology services
Industry
Packaged software
Address
Osaki Wiz Tower Tokyo TY Japan 141-0032
IPO Date
Dec 22, 2015
Business
SMN Corporation (6185.T), formerly So-net Media Networks Corporation, is a Japan-based digital marketing technology company founded on March 21, 2000 and headquartered at Osaki Wiz Tower in Shinagawa-ku, Tokyo; it operates primarily in Japan with offices in Osaka, Nagoya, Fukuoka, Sapporo and subsidiaries including SMT Corporation, SMN Ventures, ASA Inc. and RUBY GROUPE, Inc., and functions as a subsidiary of Sony Network Communications Inc. The company provides ad technology services through its core demand side platform (DSP) Logicad, which leverages big data processing, artificial intelligence via VALIS-Engine, financial engineering and real-time bidding (RTB) to optimize advertising distribution for advertisers, marketers and agencies; affiliate services via its closed-type platform SCAN; marketing analytics tools including VALIS-Cockpit; data collection, analysis and content-based marketing solutions; and other services such as planning and sales of advertising space on the So-net portal site, News Suite news application and media revenue maximization support. In 2024, SMN Corporation completed the divestiture of its consolidated subsidiary RUBY GROUPE, Inc. to YRGLM Inc., marking a strategic portfolio adjustment; it also reported revised upward net income forecasts for fiscal 2025, reflecting improved financial performance amid ongoing digital marketing operations.

Company News

  • Pivotal SAPPHIRE Trial Data Published in The Lancet Neurology: Apitegromab Demonstrated Significant Motor Function Gains for Children and Adults with SMA on SMN-Targeted Treatment

  • Sage Therapeutics Announces First Quarter 2023 Financial Results and Highlights Pipeline and Business Progress

  • Sage Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Highlights Pipeline and Business Progress

  • Sage Therapeutics Announces Third Quarter 2022 Financial Results and Highlights Pipeline and Business Progress

  • Sage Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Pipeline and Business Progress

  • Sage Therapeutics Announces First Quarter 2022 Financial Results and Highlights Pipeline and Business Progress

  • Sage Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Highlights Pipeline and Business Progress

  • Sage Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Pipeline and Business Progress

  • Sage Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress

  • Sage Therapeutics Announces First Quarter 2021 Financial Results and Highlights Pipeline and Business Progress

  • Sage Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress